Published in Blood Weekly, January 14th, 2010
"Similarly, in Folt's FeCl3-induced carotid injury model, both CD151+/- and CD151-/- mice showed more prolonged times to 95% vessel occlusion than CD151+/+ mice. In addition,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.